glp-1 yeast infection How Medications Like Ozempic Can Affect Vaginal Health Do GLP-1 Medications Cause Yeast

IL-23 signaling prevents ferroptosis-driven renal immunopathology during candidiasis

Findings published in a preprint from a phase I clinical trial on the GLP1glucagon receptor co-agonist NN1177 in adults with overweight or obesity have raised problems with deterioration of glucose tolerance and other safety concerns, despite inducing weight loss, which illustrates the difficulties in getting the agonist balance right during the preclinical development of co-agonist therapies 6,7

Learn about the side effects, and potential benefits of DSIP peptide here

Andy De Santis RD MPH Emerging Evidence Resistant Starch Click the graphic below to learn more!

The product is offered as Research Use Only (RUO) material

Natarajan et al., 2014